Adam Kimbrough1, Jenni Kononoff2, Sierra Simpson1,2, Marsida Kallupi1, Sharona Sedighim1, Kenia Palomino3, Dana Conlisk2, Jeremiah D Momper3, Giordano de Guglielmo1, Olivier George4. 1. Department of Psychiatry, School of Medicine, University of California San Diego, 9500 Gilman Drive, MC 0714, La Jolla, CA, 92093-0737, USA. 2. Department of Neuroscience, The Scripps Research Institute, La Jolla, CA, 92037, USA. 3. Skaggs School of Pharmacy and Pharmaceutical Sciences, University of California San Diego, La Jolla, CA, 92093, USA. 4. Department of Psychiatry, School of Medicine, University of California San Diego, 9500 Gilman Drive, MC 0714, La Jolla, CA, 92093-0737, USA. olgeorge@health.ucsd.edu.
Abstract
RATIONALE: Over the last decade, oxycodone has become one of the most widely abused drugs in the USA. Oxycodone use disorder (OUD) is a serious health problem that has prompted a need to develop animal models of OUD that have both face and predictive validity. Oxycodone use in humans is more prevalent in women and leads to pronounced hyperalgesia and irritability during withdrawal. However, unclear is whether current animal models of oxycodone self-administration recapitulate these characteristics in humans. OBJECTIVES: We assessed the face validity of a model of extended-access oxycodone self-administration in rats by examining the escalation of oxycodone intake and behavioral symptoms of withdrawal, including irritability-like behavior and mechanical nociception, in male and female Wistar rats. RESULTS: Both male and female rats escalated their oxycodone intake over fourteen 12-h self-administration sessions. After escalation, female rats administered more drug than male rats. No differences in plasma oxycodone levels were identified, but males had a significantly higher level of oxycodone in the brain at 30 min. Extended access to oxycodone significantly decreased aggressive-like behavior and increased defensive-like behaviors when tested immediately after a 12-h self-administration session, followed by a rebound increase in aggressive-like behavior 12 h into withdrawal. Tests of mechanical nociception thresholds during withdrawal indicated pronounced hyperalgesia. No sex differences in irritability-like behavior or pain sensitivity were observed. CONCLUSIONS: The present study demonstrated the face validity of the extended access model of oxycodone self-administration by identifying sex differences in the escalation of oxycodone intake and pronounced changes in pain and affective states.
RATIONALE: Over the last decade, oxycodone has become one of the most widely abused drugs in the USA. Oxycodone use disorder (OUD) is a serious health problem that has prompted a need to develop animal models of OUD that have both face and predictive validity. Oxycodone use in humans is more prevalent in women and leads to pronounced hyperalgesia and irritability during withdrawal. However, unclear is whether current animal models of oxycodone self-administration recapitulate these characteristics in humans. OBJECTIVES: We assessed the face validity of a model of extended-access oxycodone self-administration in rats by examining the escalation of oxycodone intake and behavioral symptoms of withdrawal, including irritability-like behavior and mechanical nociception, in male and female Wistar rats. RESULTS: Both male and female rats escalated their oxycodone intake over fourteen 12-h self-administration sessions. After escalation, female rats administered more drug than male rats. No differences in plasma oxycodone levels were identified, but males had a significantly higher level of oxycodone in the brain at 30 min. Extended access to oxycodone significantly decreased aggressive-like behavior and increased defensive-like behaviors when tested immediately after a 12-h self-administration session, followed by a rebound increase in aggressive-like behavior 12 h into withdrawal. Tests of mechanical nociception thresholds during withdrawal indicated pronounced hyperalgesia. No sex differences in irritability-like behavior or pain sensitivity were observed. CONCLUSIONS: The present study demonstrated the face validity of the extended access model of oxycodone self-administration by identifying sex differences in the escalation of oxycodone intake and pronounced changes in pain and affective states.
Entities:
Keywords:
Aggression; Defensive; Hyperalgesia; Irritability; Opioid; Oxycodone; Pain; Self-administration; Sex differences; von Frey test
Authors: Paula E Park; Joel E Schlosburg; Leandro F Vendruscolo; Gery Schulteis; Scott Edwards; George F Koob Journal: Addict Biol Date: 2013-12-13 Impact factor: 4.280
Authors: Marsida Kallupi; Lieselot L G Carrette; Jenni Kononoff; Leah C Solberg Woods; Abraham A Palmer; Paul Schweitzer; Olivier George; Giordano de Guglielmo Journal: Proc Natl Acad Sci U S A Date: 2020-01-13 Impact factor: 11.205
Authors: Adam Kimbrough; Giordano de Guglielmo; Jenni Kononoff; Marsida Kallupi; Eric P Zorrilla; Olivier George Journal: Alcohol Clin Exp Res Date: 2017-09-22 Impact factor: 3.455
Authors: Sudie E Back; Rebecca L Payne; Amy Herrin Wahlquist; Rickey E Carter; Zachary Stroud; Louise Haynes; Maureen Hillhouse; Kathleen T Brady; Walter Ling Journal: Am J Drug Alcohol Abuse Date: 2011-09 Impact factor: 3.829
Authors: Ami Cohen; Jennifer Treweek; Scott Edwards; Rodrigo Molini Leão; Gery Schulteis; George F Koob; Olivier George Journal: Addict Biol Date: 2013-07-22 Impact factor: 4.280
Authors: Julien C Dodu; Rebecca K Moncayo; M Imad Damaj; Joel E Schlosburg; Hamid I Akbarali; Lesley D O'Brien; Debra A Kendall; Zhixing Wu; Dai Lu; Aron H Lichtman Journal: J Pharmacol Exp Ther Date: 2021-10-08 Impact factor: 4.402
Authors: Yu Fu; Irene Lorrai; Barry Zorman; Daniele Mercatelli; Chase Shankula; Jorge Marquez Gaytan; Celine Lefebvre; Giordano de Guglielmo; Hyunjae Ryan Kim; Pavel Sumazin; Federico M Giorgi; Vez Repunte-Canonigo; Pietro Paolo Sanna Journal: Viruses Date: 2022-03-24 Impact factor: 5.818